Belimo Automation AG
- ISIN: CH0001503199
- Land: Schweiz
Nachricht vom 20.02.2020 | 07:00
Belimo Holding AG: Belimo to Nominate Stefan Ranstrand for Election to the Board of Directors
Belimo Holding AG / Key word(s): Personnel
Hinwil (Switzerland), EMBARGOED UNTIL February 20, 2020, 7.00 a.m. CET Press Release of the Belimo Group
Belimo to Nominate Stefan Ranstrand for Election to the Board of Directors
The Board of Directors of BELIMO Holding AG will nominate Stefan Ranstrand for election to the previous five-member body at the upcoming Annual General Meeting.
As part of its long-term succession planning, the Board of Directors has decided to nominate Stefan Ranstrand as a new Member.
Stefan Ranstrand holds a Master of Science degree in Industrial and Management Engineering, which he received from the University of Technology Darmstadt (Germany), and the University Linköping (Sweden). He is President and CEO of Tomra Systems ASA, Asker (Norway), which is specialised in recycling solutions. Prior to that, Stefan Ranstrand has been working in various executive positions for ABB Ltd. in China, Japan, Malaysia, Switzerland and the Czech Republic.
The Board of Directors is convinced that Stefan Ranstrand is a very suitable candidate for recommendation to the Annual General Meeting. Thanks to his successful track record as CEO of a globally active and listed industrial company, his expertise in Asia Pacific as well as his personality matching the culture of the Company he will ideally complement the Board of Directors of Belimo.
The Belimo Group is a leading global manufacturer of innovative electrical actuator, valve, and sensor solutions for heating, ventilation, and air conditioning systems. The Company reported sales of CHF 693 million in 2019 and has approximately 1,900 employees. Information about the Company and its products is available on the internet at www.belimo.com.
The shares of BELIMO Holding AG have been traded on the SIX Swiss Exchange since 1995 (BEAN).
BELIMO Holding AG
End of ad hoc announcement
|Company:||Belimo Holding AG|
|Phone:||+41 43 843 63 80|
|Fax:||+41 43 843 62 41|
|Listed:||SIX Swiss Exchange|
|EQS News ID:||957819|
|End of Announcement||EQS Group News Service|
GBC im Fokus
IGEA Pharma N.V. Realignment to CBD extraction
The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.
Der AKTIONÄR News
06. Dezember 13:15 Bitcoin: "High-Risk" und "Chance auf 100.000 Dollar"
06. Dezember 13:45 Munich Re: Das schaut viel besser aus
06. Dezember 14:15 Allianz dealt mit BASF – Aktie hat Rückenwind
06. Dezember 14:15 Deutsche Nebenwerte: Starke Aussichten
06. Dezember 14:18 Thyssenkrupp auf Talfahrt - das macht Hoffnung auf die Trendwende
FY 2020/2021 Financial Results
16. Dezember 2021
Original-Research: PSI AG (von First Berlin Equity Research GmbH): Hinzufügen
06. Dezember 2021